<?xml version="1.0" encoding="UTF-8"?>
<p>Although anti-RSV antibodies treatment represent a very different approach to FPI treatment, the need for very early treatment raise the question as to whether combining an NSAID as an immunomodulator to FPI therapy would result in better outcomes than monotherapy with an FPI.</p>
